Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also

J. M. S. Bartlett; C. C. Mcconkey; A. F. Munro; C. Desmedt; J. A. Dunn; D. P. Larsimont; F. P. O'malley; D. A. Cameron; H. M. Earl; C. J. Poole; L. E. Shepherd; F. Cardoso; M.-b. Jensen; C. Caldas; C. J. Twelves; D. W. Rea; B. Ejlertsen; A. Di Leo; K. I. Pritchard

doi:10.1200/JCO.2013.54.7869

Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also

J. M. S. Bartlett, C. C. Mcconkey, A. F. Munro, C. Desmedt, J. A. Dunn, D. P. Larsimont, F. P. O'malley, D. A. Cameron, H. M. Earl, C. J. Poole, L. E. Shepherd, F. Cardoso, M.-b. Jensen, C. Caldas, C. J. Twelves, D. W. Rea, B. Ejlertsen, A. Di Leo, K. I. Pritchard

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1680-1687
Journal	Journal of Clinical Oncology
Volume	33
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2013.54.7869
Publication status	Published - 20 May 2015

Access to Document

10.1200/JCO.2013.54.7869

http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.7869

Cite this

Bartlett, J. M. S., Mcconkey, C. C., Munro, A. F., Desmedt, C., Dunn, J. A., Larsimont, D. P., O'malley, F. P., Cameron, D. A., Earl, H. M., Poole, C. J., Shepherd, L. E., Cardoso, F., Jensen, M., Caldas, C., Twelves, C. J., Rea, D. W., Ejlertsen, B., Di Leo, A., & Pritchard, K. I. (2015). Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also. Journal of Clinical Oncology, 33(15), 1680-1687. https://doi.org/10.1200/JCO.2013.54.7869

@article{7e160d0e37c54d2392419587d5ecc2cf,

title = "Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also",

author = "Bartlett, {J. M. S.} and Mcconkey, {C. C.} and Munro, {A. F.} and C. Desmedt and Dunn, {J. A.} and Larsimont, {D. P.} and O'malley, {F. P.} and Cameron, {D. A.} and Earl, {H. M.} and Poole, {C. J.} and Shepherd, {L. E.} and F. Cardoso and M.-b. Jensen and C. Caldas and Twelves, {C. J.} and Rea, {D. W.} and B. Ejlertsen and {Di Leo}, A. and Pritchard, {K. I.}",

year = "2015",

month = may,

day = "20",

doi = "10.1200/JCO.2013.54.7869",

language = "English",

volume = "33",

pages = "1680--1687",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

Bartlett, JMS, Mcconkey, CC, Munro, AF, Desmedt, C, Dunn, JA, Larsimont, DP, O'malley, FP, Cameron, DA, Earl, HM, Poole, CJ, Shepherd, LE, Cardoso, F, Jensen, M, Caldas, C, Twelves, CJ, Rea, DW, Ejlertsen, B, Di Leo, A & Pritchard, KI 2015, 'Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also', Journal of Clinical Oncology, vol. 33, no. 15, pp. 1680-1687. https://doi.org/10.1200/JCO.2013.54.7869

TY - JOUR

T1 - Predicting Anthracycline Benefit: TOP2A and CEP17--Not Only but Also

AU - Bartlett, J. M. S.

AU - Mcconkey, C. C.

AU - Munro, A. F.

AU - Desmedt, C.

AU - Dunn, J. A.

AU - Larsimont, D. P.

AU - O'malley, F. P.

AU - Cameron, D. A.

AU - Earl, H. M.

AU - Poole, C. J.

AU - Shepherd, L. E.

AU - Cardoso, F.

AU - Jensen, M.-b.

AU - Caldas, C.

AU - Twelves, C. J.

AU - Rea, D. W.

AU - Ejlertsen, B.

AU - Di Leo, A.

AU - Pritchard, K. I.

PY - 2015/5/20

Y1 - 2015/5/20

U2 - 10.1200/JCO.2013.54.7869

DO - 10.1200/JCO.2013.54.7869

M3 - Article

SN - 0732-183X

VL - 33

SP - 1680

EP - 1687

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -